Neogen Corporation's revenue has shrunk 1.3% a year over three years, and grown 13% a year over five. Revenue growth, 3-year annual rate: −1.3% (Medical Devices median +11%). Revenue growth, 5-year rate: +13%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2010 to FY2026, as filed.

NEOGNeogen Corporation

Healthcare

$12.19+106% 1Y

$12.19

$5.4152 weeks$13.99

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+117.7 points).

1 good, 1 neutral, 1 without data

Revenue trend−0% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Margin direction+117.7 points operating

Trailing-twelve-month operating margin, -0.8% now against -118.5% a year earlier.

All from SEC EDGAR, as of Aug 31, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 85% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is NEOG growing?

Neogen Corporation's revenue has shrunk 1.3% a year over three years, and grown 13% a year over five.

−1.3%

Revenue growth, 3-year annual rate · Medical Devices median +11% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · −1.3% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2010 to FY2026, as filed

Details›